Identifier to cite or link to this item: http://hdl.handle.net/20.500.13003/11335
Prevalence of Premorbid Metabolic Syndrome in Spanish Adult Workers Using IDF and ATPIII Diagnostic Criteria: Relationship with Cardiovascular Risk Factors
Identifiers
ISSN: 1932-6203
WOS ID: 000331714700085
Scopus EID: 2-s2.0-84895869485
PMID: 24586656
Embase PUI: L372566103
Share
Statistics
Item usage statisticsMetadata
Show Dublin Core item recordPublication date
2014-02-20Document type
research articleCitation
Tauler Riera P, Bennasar-Veny M, Morales-Asencio JM, Lopez Gonzalez AA, Vicente-Herrero T, Ernest De Pedro Gomez J, et al. Prevalence of Premorbid Metabolic Syndrome in Spanish Adult Workers Using IDF and ATPIII Diagnostic Criteria: Relationship with Cardiovascular Risk Factors. PLoS One. 2014 Feb 20;9(2):e89281.Abstract
Background: Metabolic Syndrome (MetS) is a complex disorder defined as a cluster of interconnected risk factors such as hypertension, dyslipidemia, obesity and high blood glucose levels. Premorbid metabolic syndrome (PMetS) is defined by excluding patients with previously diagnosed cardiovascular disease or diabetes mellitus from those suffering MetS. We aimed to determine the prevalence of PMetS in a working population, and to analyse the relationship between the diagnostic criteria of the International Diabetes Federation (IDF) and of the National Cholesterol Education Program Adult Treatment Panel III (ATPIII). The relationship between the presence of PMetS and cardiovascular risk factors was also analysed. Research Methodology/Findings: A cross-sectional study was conducted in 24,529 male and 18,736 female Spanish (white western European) adult workers (20-65 years) randomly selected during their work health periodic examinations. Anthropometrics, blood pressure and serum parameters were measured. The presence of MetS and PMetS was ascertained using ATPIII and IDF criteria. Cardiovascular risk was determined using the Framingham-REGICOR equation. The results showed MetS had an adjusted global prevalence of 12.39% using ATPIII criteria and 16.46% using IDF criteria. The prevalence of PMetS was slightly lower (11.21% using ATPIII criteria and 14.72% using IDF criteria). Prevalence in males was always higher than in females. Participants with PMetS displayed higher values of BMI, waist circumference, blood pressure, glucose and triglycerides, and lower HDL-cholesterol levels. Logistic regression models reported lower PMetS risk for females, non-obese subjects, non-smokers and younger participants. Cardiovascular risk determined with Framingham-REGICOR was higher in participants with PMetS. Conclusions: PMetS could be a reliable tool for the early identification of apparently healthy individuals who have a significant risk for developing cardiovascular events and type 2 diabetes.
Publisher version
https://dx.doi.org/10.1371/journal.pone.0089281MeSH
Cardiovascular DiseasesDiabetes Mellitus, Type 2
Metabolic Syndrome
Triglycerides
Young Adult
Spain
Adult
Follow-Up Studies
Humans
Hypertension
Middle Aged
Cross-Sectional Studies
Obesity
Prognosis
Male
Female
Risk Factors
Prevalence
DeCS
PrevalenciaSíndrome Metabólico
Femenino
Masculino
Estudios de Seguimiento
Hipertensión
Estudios Transversales
Factores de Riesgo
Humanos
Persona de Mediana Edad
Obesidad
Adulto Joven
Pronóstico
Diabetes Mellitus Tipo 2
Enfermedades Cardiovasculares
Triglicéridos
Adulto
España
This item appears in following Docusalut collections
Hospital de Manacor - HMAN > Comunicación científicaInstituto de Investigación Sanitaria Islas Baleares - IDISBA > Comunicación científica
Servicio de Salud de las Islas Baleares - IBSALUT > Comunicación científica